(Q34388554)

1 August 2017

1 reference

title

C1-inhibitor: an anti-inflammatory reagent with therapeutic potential (English)

1 reference

1 August 2017

0 references

2

Mollnes TE

1 reference

1 August 2017

Kirschfink M

1

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

Expert Opinion on Pharmacotherapy

1 August 2017

published in

1 reference

1 August 2017

volume

2

1 reference

1 August 2017

issue

7

1 reference

1 August 2017

page(s)

1073-1083

1 reference

Molecular organization and function of the complement system

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1073

The mannan-binding-lectin pathway of the innate immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1073

Control of the complement system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1073

Complement in the pathophysiology and diagnosis of human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1073

Controlling the complement system in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1073

C1 inhibitor in anti-inflammatory therapy: from animal experiment to clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1073

Molecular cloning of human C1 inhibitor: sequence homologies with alpha 1-antitrypsin and other members of the serpins superfamily.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1073

Human C1 inhibitor: primary structure, cDNA cloning, and chromosomal localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1073

Interaction of 125I-labelled complement subcomponents C-1r and C-1s with protease inhibitors in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1073

The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1073

Inactivation of kallikrein in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1073

Identification of a serpin-enzyme complex receptor on human hepatoma cells and human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1073

Behavior in vivo of normal and dysfunctional C1 inhibitor in normal subjects and patients with hereditary angioneurotic edema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1073

Proteolytic inactivation of plasma C1- inhibitor in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1073

Heparin binding and augmentation of C1 inhibitor activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1073

Low molecular weight dextran sulfate prevents complement activation and delays hyperacute rejection in pig-to-human xenotransplantation models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1073

C1 inhibitor and hereditary angioneurotic edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1073

Long-term prophylaxis with C1-inhibitor (C1 INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibitor deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1073

Reduction in transmission of hepatitis C after the introduction of a heat-treatment step in the production of C1-inhibitor concentrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1073

Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1073

Hepatic veno-occlusive disease with severe capillary leakage after peripheral stem cell transplantation: treatment with recombinant plasminogen activator and C1-esterase inhibitor concentrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1073

Endotoxin-induced pulmonary dysfunction is prevented by C1-esterase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1073

Septic shock after liver transplantation for Caroli's disease: clinical improvement after treatment with C1-esterase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1073

Rescue therapy with C1-esterase inhibitor concentrate after emergency coronary surgery for failed PTCA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1073

C1-esterase inhibitor reduces infarct volume after cortical vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1073

Complement deposition in early cardiac transplant biopsies is associated with ischemic injury and subsequent rejection episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1073

The role of complement in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1073

Improved right ventricular function after intracoronary administration of a C1 esterase inhibitor in a right heart transplantation model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1073

Role of complement in xenotransplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1073

C1-inhibitor attenuates hyperacute rejection and inhibits complement, leukocyte and platelet activation in an ex vivo pig-to-human perfusion model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1073

A surface-bound form of human C1 esterase inhibitor improves xenograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1073

Regulation of complement-mediated swine endothelial cell lysis by a surface-bound form of human C4b binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1073

Complement activation, its consequences, and blockade by gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1073

Potential use of genetically modified pigs as organ donors for transplantation into humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1073

Complement C1-inhibitor expression in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1073

Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1073

Complement regulators C1 inhibitor and CD59 do not significantly inhibit complement activation in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1073

Recombinant C1 inhibitor P5/P3 variants display resistance to catalytic inactivation by stimulated neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.7.1073

10.1517/14656566.2.7.1073

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference